Douglas Holtzman, Chief Scientific Officer at Icosavax, Inc. (ICVX), sold 39,712 shares at $6.64 ($131K) on 2022-08-01, disclosed to the SEC on 2022-08-02.
Open-market sale of $131k ICVX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 20,000 | $0 | 0.0% |
| 2 | $7.11 | 585 | $4K | 3.2% |
| 3 | $6.64 | 9,337 | $62K | 47.3% |
| 4 | $6.64 | 9,337 | $62K | 47.3% |
| 5 | $6.70 | 453 | $3K | 2.3% |
| Total | $3.30 avg | 39,712 |
| $131K |
| 100% |
| Filing → |
| ICVX | SELL | 2023-02-15 | $50K | — | Filing → |
| ICVX | SELL | 2022-12-16 | $438K | — | Filing → |